Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

H. Lundbeck: Clinical Trials & FDA Approval Profile

H. Lundbeck (Global / Institutional) sponsors 22 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 9 active protocols (5 recruiting now), 10 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)13.6%
Median Closed Enrollment vs National (145 pts)181 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for H. Lundbeck
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)22
Active Pipeline (Recruiting Now)9 (5)
Completed vs Stopped Early10 / 3 (13.6%)
Median Closed Actual Enrollment181 participants
Physical Hospital Site Disclosure99.7% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With H. Lundbeck
Hospital Research SiteLocationShared Protocols
Hospital Universitari Vall d'HebronBarcelona7
Yale Cancer Center and Smilow Cancer HospitalNew Haven, CT4

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by H. Lundbeck
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT04965675A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic MigrainePhase IIIRECRUITING
NCT05164172A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic MigrainePhase IIIRECRUITING
NCT05897320A Study of Eptinezumab in Pediatric Participants With Episodic MigrainePhase IIIRECRUITING
NCT05104476A Study of Lu AF82422 in Participants With Multiple System AtrophyPhase IIACTIVE NOT RECRUITING
NCT06471829A Trial of Lu AG13909 in Adult Participants With Cushing's DiseasePhase IIACTIVE NOT RECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the H. Lundbeck Interactive Dossier, benchmark peers in Neurology, Psychiatry, and Pain, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI